Innovate Biopharmaceuticals, Inc. announced that upon commencement of Mr. Sitar's employment, Jay P. Madan, M.S., will no longer serve as the interim principal financial officer and interim principal accounting officer of the company, but will continue to serve as the President and Chief Business Officer of the company.